The Babraham Institute Revenue and Competitors
Estimated Revenue & Valuation
- The Babraham Institute's estimated annual revenue is currently $58.6M per year.
- The Babraham Institute's estimated revenue per employee is $127,500
Employee Data
- The Babraham Institute has 460 Employees.
The Babraham Institute's People
Name | Title | Email/Phone |
---|---|---|
1 | Graduate Studies Officer | Reveal Email/Phone |
2 | Head Governance and Projects | Reveal Email/Phone |
3 | Human Resources Officer | Reveal Email/Phone |
4 | Head Information Technology | Reveal Email/Phone |
5 | Head Human Resources | Reveal Email/Phone |
6 | Head Research Operations & Deputy Director, Operations | Reveal Email/Phone |
7 | Head Communications | Reveal Email/Phone |
8 | Head Immunology Programme/ Associate Institute Director | Reveal Email/Phone |
9 | Knowledge Exchange and Commercialisation Officer | Reveal Email/Phone |
10 | Grants Officer | Reveal Email/Phone |
The Babraham Institute Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $6.1M | 69 | -13% | $16.5M | N/A |
#2 | $264.2M | 1850 | -1% | N/A | N/A |
#3 | $51.9M | 401 | -10% | $12.6M | N/A |
#4 | $22.5M | 205 | -39% | $63.8M | N/A |
#5 | $1.1M | 21 | -19% | $781.7K | N/A |
#6 | $21.3M | 190 | 33% | N/A | N/A |
#7 | $11.9M | 117 | 10% | N/A | N/A |
#8 | $3.8M | 46 | -10% | N/A | N/A |
#9 | $8.8M | 86 | -16% | N/A | N/A |
#10 | $2.5M | 31 | -40% | N/A | N/A |
What Is The Babraham Institute?
The Babraham Institute receives funding from the Biotechnology and Biological Sciences Research Council (BBSRC) and carries out world-leading research to generate new knowledge of biological mechanisms underpinning ageing, development and the maintenance of health. Our research is focussed on four main science programmes; Epigenetics - a branch of genetics research which studies modifications to DNA that affect gene activity, it helps to explain how our environment and lifestyle can affect our behavior or likelihood of getting diseases. Immunology - the study of the immune system, which recognises and fights diseases in our bodies. Research in this area can lead to improvements in vaccines, combat autoimmune disease, develop tumour immunotherapy or improve the efficiency of organ transplantation. Signalling - researching communication within and between the cells in our body, which underpins how cells and organs develop and respond to changes in their environment, vital for maintaining health. Research in this area is identifying new targets for treatment of cancer. Nuclear Dynamics - studying how DNA is packaged inside the cells in order for the genome to function correctly. This is shedding light on why we may have susceptibility to developing cancers as well as providing insight into the coordination of gene expression and physiological functions in relation to health and ageing. Epigenetics, Nuclear Dynamics, Signalling, Immunology
keywords:N/AN/A
Total Funding
460
Number of Employees
$58.6M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
The Babraham Institute News
Research from the Babraham Institute has developed a method to 'time jump' human skin cells by 30 years, turning back the ageing clock for...
The head of the team, Prof Wolf Reik, of the Babraham Institute in Cambridge, told BBC News that he hoped that the technique could...
Babraham Institute in Cambridge announced on Thursday researchers had successfully rejuvenated skin cells. · Scientists reprogrammed adult skin...
Limiting inflammation may improve ‘flu vaccination response in older people 05-11-2021 By analysing immune responses across people of different ages after seasonal influenza vaccination, immunologists at the Babraham Institute have shown that a particular type of white blood cell, circulating ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $93.1M | 463 | 6% | N/A |
#2 | $84.1M | 464 | -17% | N/A |
#3 | $105.5M | 469 | 35% | N/A |
#4 | $155.3M | 471 | 0% | $402.8M |
#5 | N/A | 473 | 7% | N/A |